CODX Historical Financial Ratios
CODX Stock | USD 0.81 0.03 3.56% |
Co Diagnostics is presently reporting on over 109 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Dividend Yield of 0.0, PTB Ratio of 0.43 or Days Sales Outstanding of 16.84 will help investors to properly organize and evaluate Co Diagnostics financial condition quickly.
CODX |
About CODX Financial Ratios Analysis
Co DiagnosticsFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Co Diagnostics investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on CODX financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Co Diagnostics history.
Co Diagnostics Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Co Diagnostics stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Co Diagnostics sales, a figure that is much harder to manipulate than other Co Diagnostics multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Average Payables
The average amount owed to suppliers and creditors over a specific period, reflecting the company's payment cycle and credit terms with suppliers.Ev To Sales
The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.Most ratios from Co Diagnostics' fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Co Diagnostics current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Co Diagnostics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. For more information on how to buy CODX Stock please use our How to Invest in Co Diagnostics guide.At this time, Co Diagnostics' Book Value Per Share is fairly stable compared to the past year. Average Payables is likely to rise to about 1.2 M in 2024, whereas Price To Sales Ratio is likely to drop 5.44 in 2024.
2021 | 2022 | 2023 | 2024 (projected) | Payables Turnover | 19.05 | 5.76 | 2.82 | 2.68 | Days Of Inventory On Hand | 63.2 | 353.64 | 145.19 | 137.93 |
Co Diagnostics fundamentals Correlations
Click cells to compare fundamentals
Co Diagnostics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Co Diagnostics fundamentals Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Price To Sales Ratio | 69.76 | 3.33 | 2.63 | 2.32 | 5.73 | 5.44 | |
Ptb Ratio | 8.63 | 3.73 | 1.92 | 0.69 | 0.45 | 0.43 | |
Days Sales Outstanding | 223.07 | 59.42 | 77.99 | 57.59 | 17.73 | 16.84 | |
Book Value Per Share | 0.1 | 2.5 | 4.66 | 3.64 | 2.93 | 3.08 | |
Free Cash Flow Yield | (0.38) | 0.11 | 0.16 | 0.0648 | (0.6) | (0.57) | |
Stock Based Compensation To Revenue | 5.06 | 0.0367 | 0.0563 | 0.22 | 1.22 | 1.16 | |
Capex To Depreciation | 0.81 | 1.72 | 5.59 | 2.0 | 1.11 | 1.53 | |
Pb Ratio | 8.63 | 3.73 | 1.92 | 0.69 | 0.45 | 0.43 | |
Ev To Sales | 65.61 | 2.76 | 1.73 | 1.66 | 3.98 | 3.78 | |
Free Cash Flow Per Share | (0.34) | 1.03 | 1.4 | 0.16 | (0.8) | (0.76) | |
Roic | (3.32) | 0.62 | 0.28 | (0.0763) | (0.46) | (0.48) | |
Inventory Turnover | 0.57 | 2.08 | 5.78 | 1.03 | 2.51 | 1.43 | |
Net Income Per Share | (0.36) | 1.59 | 1.27 | (0.45) | (1.2) | (1.14) | |
Days Of Inventory On Hand | 640.09 | 175.89 | 63.2 | 353.64 | 145.19 | 137.93 | |
Payables Turnover | 18.87 | 27.73 | 19.05 | 5.76 | 2.82 | 2.68 | |
Sales General And Administrative To Revenue | 16.27 | 0.11 | 0.12 | 0.42 | 2.1 | 1.99 | |
Research And Ddevelopement To Revenue | 6.38 | 0.0427 | 0.15 | 0.51 | 3.37 | 3.2 | |
Capex To Revenue | 0.53 | 0.0104 | 0.006839 | 0.0417 | 0.2 | 0.19 | |
Cash Per Share | 0.0533 | 1.77 | 3.11 | 2.58 | 2.0 | 2.09 | |
Pocfratio | (2.71) | 8.82 | 6.28 | 12.08 | (1.77) | (1.86) | |
Interest Coverage | (14.71) | (45.33) | (55.37) | (0.78) | (0.9) | (0.94) | |
Capex To Operating Cash Flow | (0.0205) | 0.0275 | 0.0163 | 0.22 | (0.0618) | (0.0587) | |
Pfcf Ratio | (2.66) | 9.07 | 6.38 | 15.43 | (1.66) | (1.75) | |
Days Payables Outstanding | 19.35 | 13.16 | 19.16 | 63.42 | 129.27 | 122.8 | |
Income Quality | 0.89 | 0.66 | 1.12 | (0.46) | 0.62 | 0.69 | |
Ev To Operating Cash Flow | (2.55) | 7.3 | 4.12 | 8.63 | (1.23) | (1.29) | |
Pe Ratio | (2.47) | 5.85 | 7.03 | (5.57) | (1.1) | (1.16) | |
Return On Tangible Assets | (2.74) | 0.58 | 0.31 | (0.15) | (0.51) | (0.54) | |
Ev To Free Cash Flow | (2.5) | 7.5 | 4.19 | 11.03 | (1.16) | (1.21) | |
Earnings Yield | (0.4) | 0.17 | 0.14 | (0.18) | (0.91) | (0.86) | |
Net Debt To E B I T D A | 0.15 | (1.03) | (1.91) | 2.19 | 0.29 | 0.3 | |
Current Ratio | 4.83 | 15.16 | 9.14 | 23.94 | 10.81 | 5.9 | |
Tangible Book Value Per Share | 0.1 | 2.57 | 3.21 | 2.79 | 2.03 | 2.13 | |
Receivables Turnover | 1.64 | 6.14 | 4.68 | 6.34 | 20.59 | 21.62 | |
Graham Number | 0.92 | 9.45 | 11.53 | 6.08 | 8.91 | 9.36 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for CODX Stock Analysis
When running Co Diagnostics' price analysis, check to measure Co Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Co Diagnostics is operating at the current time. Most of Co Diagnostics' value examination focuses on studying past and present price action to predict the probability of Co Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Co Diagnostics' price. Additionally, you may evaluate how the addition of Co Diagnostics to your portfolios can decrease your overall portfolio volatility.